efavirenz and nbd 556
efavirenz has been researched along with nbd 556 in 2 studies
Research
Studies (2)
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
Authors
| Authors | Studies |
|---|---|
| Harada, S; Kobayakawa, T; Konno, K; Masuda, A; Ohashi, N; Takahashi, K; Tamamura, H; Yoshimura, K | 1 |
| Dranchak, PK; Huang, R; Inglese, J; Lamy, L; Oliphant, E; Queme, B; Tao, D; Wang, Y; Xia, M | 1 |
Other Studies
2 other study(ies) available for efavirenz and nbd 556
| Article | Year |
|---|---|
Soluble-type small-molecule CD4 mimics as HIV entry inhibitors.
Topics: Antibodies, Neutralizing; CD4 Antigens; HIV Fusion Inhibitors; HIV-1; Humans; Molecular Mimicry; Small Molecule Libraries; Solubility; Structure-Activity Relationship | 2019 |
In vivo quantitative high-throughput screening for drug discovery and comparative toxicology.
Topics: Animals; Caenorhabditis elegans; Drug Discovery; High-Throughput Screening Assays; Humans; Proteomics; Small Molecule Libraries | 2023 |